Skip to main content
Exicon Co., Ltd. logo

Exicon Co., Ltd. — Investor Relations & Filings

Ticker · 092870 ISIN · KR7092870005 KO Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2016-05-26 Major Shareholding Noti…
Country KR South Korea
Listing KO 092870

About Exicon Co., Ltd.

https://www.exicon.co.kr/en/

Exicon Co., Ltd. is a global semiconductor test solution provider that develops and manufactures test equipment. The company's product portfolio includes testers for memory, storage, and System on Chip (SoC) devices. Exicon specializes in the final test, or packaging test, stage of the semiconductor manufacturing process. It is expanding its capabilities to become a comprehensive testing business that provides integrated solutions for both memory and non-memory semiconductor devices.

Recent filings

Filing Released Lang Actions
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is titled 'Major shareholder announcement' and states that Morgan Stanley & Co. International plc owns less than 5% of the share capital and voting rights in Exiqon A/S. This indicates a notification about changes in significant share ownership levels. The document is short (1476 characters) and does not contain financial statements or detailed analysis. Therefore, it fits the category of Major Shareholding Notification (MRQ).
2016-05-26 English
Storaktionærmeddelelse
Major Shareholding Notification Classification · 90% confidence The document is a notification that a shareholder (Morgan Stanley & Co. International plc) has fallen below the 5% ownership threshold in Exiqon A/S. This is a classic Major Shareholding Notification, informing the market of a change in significant share ownership levels.
2016-05-26 English
Fejler overtagelsestilbud risikerer Exiqon på kort sigt selskabets profitabilitet og planlægger en kapitalforhøjelse for at accelerere life science strategien.
Capital/Financing Update Classification · 95% confidence The document is an announcement from Exiqon A/S regarding the potential failure of a takeover offer by QIAGEN N.V. It discusses strategic plans if the takeover does not complete, including a capital increase and changes in business focus. The content centers on financing plans, strategic shifts, and a planned extraordinary general meeting to approve a capital increase. There are no detailed financial statements or comprehensive financial performance data presented, which would be required for an Interim/Quarterly Report or Annual Report. The document is primarily an update on financing and strategic plans related to capital structure and fundraising. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4658 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2016-05-24 English
Fejler overtagelsestilbud risikerer Exiqon på kort sigt selskabets profitabilitet og planlægger en kapitalforhøjelse for at accelerere life science strategien.
M&A Activity Classification · 92% confidence The document is a stock exchange announcement regarding a takeover offer by QIAGEN N.V. to acquire Exiqon A/S. It reiterates the Board’s support for the bid, describes an extension of the offer period, fallback plans if the offer fails, and subsequent strategic financing and EGM for share capital increase. This falls squarely under announcements related to merger proposals or takeover bids.
2016-05-24 English
Fejler overtagelsestilbud risikerer Exiqon på kort sigt selskabets profitabilitet og planlægger en kapitalforhøjelse for at accelerere life science strategien.
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Exiqon A/S dated May 24, 2016, discussing the company's strategic plans in response to a takeover bid from QIAGEN N.V. It mentions the risk to profitability if the takeover bid fails and plans for a capital increase to accelerate the life science strategy. The content focuses on corporate strategy, financing plans, and shareholder meeting intentions. There is no detailed financial data, quarterly or annual financial statements, or audit information. The document is not a full report but an update on capital and strategic plans related to financing and potential shareholder actions. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 4677 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2016-05-24 English
Fejler overtagelsestilbud risikerer Exiqon på kort sigt selskabets profitabilitet og planlægger en kapitalforhøjelse for at accelerere life science strategien.
M&A Activity Classification · 95% confidence The document is a stock exchange announcement (“Fondsbørsmeddelelse”) in which Exiqon A/S confirms its board’s support for a takeover bid by QIAGEN N.V., discusses potential outcomes if the offer fails, and plans for an extraordinary general meeting to approve a capital increase. This is clearly an M&A-related announcement concerning a takeover proposal. Therefore it should be classified as M&A Activity (TAR).
2016-05-24 Danish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.